United States Carbidopa Market Report 2017

January 2017 | 120 pages | ID: U0C535B095CEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Carbidopa

Revenue, means the sales value of Carbidopa

This report studies sales (consumption) of Carbidopa in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Novartis
• Merck Sharp & Dohme
• AbbVie
• Impax
• WOCKHARDT
• Allergan
• Teva Pharmaceuticals
• Mylan N.V.
• Valeant
• Jinghua Pharmaceutical

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II

Split by applications, this report focuses on sales, market share and growth rate of Carbidopa in each application, can be divided into

• Application 1
• Application 2

Contents

United States Carbidopa Market Report 2017

1 CARBIDOPA OVERVIEW

1.1 Product Overview and Scope of Carbidopa
1.2 Classification of Carbidopa
  1.2.1 Type I
  1.2.2 Type II
1.3 Application of Carbidopa
  1.3.1 Application
  1.3.2 Application
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Carbidopa (2012-2022)
  1.4.1 United States Carbidopa Sales and Growth Rate (2012-2022)
  1.4.2 United States Carbidopa Revenue and Growth Rate (2012-2022)

2 UNITED STATES CARBIDOPA COMPETITION BY MANUFACTURERS

2.1 United States Carbidopa Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Carbidopa Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Carbidopa Average Price by Manufactures (2015 and 2016)
2.4 Carbidopa Market Competitive Situation and Trends
  2.4.1 Carbidopa Market Concentration Rate
  2.4.2 Carbidopa Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES CARBIDOPA SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Carbidopa Sales and Market Share by States (2012-2017)
3.2 United States Carbidopa Revenue and Market Share by States (2012-2017)
3.3 United States Carbidopa Price by States (2012-2017)

4 UNITED STATES CARBIDOPA SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Carbidopa Sales and Market Share by Type (2012-2017)
4.2 United States Carbidopa Revenue and Market Share by Type (2012-2017)
4.3 United States Carbidopa Price by Type (2012-2017)
4.4 United States Carbidopa Sales Growth Rate by Type (2012-2017)

5 UNITED STATES CARBIDOPA SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Carbidopa Sales and Market Share by Application (2012-2017)
5.2 United States Carbidopa Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES CARBIDOPA MANUFACTURERS PROFILES/ANALYSIS

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Carbidopa Product Type, Application and Specification
    6.1.2.1
    6.1.2.2
  6.1.3 Novartis Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Merck Sharp & Dohme
  6.2.2 Carbidopa Product Type, Application and Specification
    6.2.2.1
    6.2.2.2
  6.2.3 Merck Sharp & Dohme Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 AbbVie
  6.3.2 Carbidopa Product Type, Application and Specification
    6.3.2.1
    6.3.2.2
  6.3.3 AbbVie Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Impax
  6.4.2 Carbidopa Product Type, Application and Specification
    6.4.2.1
    6.4.2.2
  6.4.3 Impax Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 WOCKHARDT
  6.5.2 Carbidopa Product Type, Application and Specification
    6.5.2.1
    6.5.2.2
  6.5.3 WOCKHARDT Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Allergan
  6.6.2 Carbidopa Product Type, Application and Specification
    6.6.2.1
    6.6.2.2
  6.6.3 Allergan Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Teva Pharmaceuticals
  6.7.2 Carbidopa Product Type, Application and Specification
    6.7.2.1
    6.7.2.2
  6.7.3 Teva Pharmaceuticals Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Mylan N.V.
  6.8.2 Carbidopa Product Type, Application and Specification
    6.8.2.1
    6.8.2.2
  6.8.3 Mylan N.V. Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Valeant
  6.9.2 Carbidopa Product Type, Application and Specification
    6.9.2.1
    6.9.2.2
  6.9.3 Valeant Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Jinghua Pharmaceutical
  6.10.2 Carbidopa Product Type, Application and Specification
    6.10.2.1
    6.10.2.2
  6.10.3 Jinghua Pharmaceutical Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 CARBIDOPA MANUFACTURING COST ANALYSIS

7.1 Carbidopa Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Carbidopa

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Carbidopa Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Carbidopa Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CARBIDOPA MARKET FORECAST (2017-2022)

11.1 United States Carbidopa Sales, Revenue Forecast (2017-2022)
11.2 United States Carbidopa Sales Forecast by Type (2017-2022)
11.3 United States Carbidopa Sales Forecast by Application (2017-2022)
11.4 Carbidopa Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Carbidopa
Table Classification of Carbidopa
Figure United States Sales Market Share of Carbidopa by Type in 2015
Table Application of Carbidopa
Figure United States Sales Market Share of Carbidopa by Application in 2015
Figure United States Carbidopa Sales and Growth Rate (2012-2022)
Figure United States Carbidopa Revenue and Growth Rate (2012-2022)
Table United States Carbidopa Sales of Key Manufacturers (2015 and 2016)
Table United States Carbidopa Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Carbidopa Sales Share by Manufacturers
Figure 2016 Carbidopa Sales Share by Manufacturers
Table United States Carbidopa Revenue by Manufacturers (2015 and 2016)
Table United States Carbidopa Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Carbidopa Revenue Share by Manufacturers
Table 2016 United States Carbidopa Revenue Share by Manufacturers
Table United States Market Carbidopa Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Carbidopa Average Price of Key Manufacturers in 2015
Figure Carbidopa Market Share of Top 3 Manufacturers
Figure Carbidopa Market Share of Top 5 Manufacturers
Table United States Carbidopa Sales by States (2012-2017)
Table United States Carbidopa Sales Share by States (2012-2017)
Figure United States Carbidopa Sales Market Share by States in 2015
Table United States Carbidopa Revenue and Market Share by States (2012-2017)
Table United States Carbidopa Revenue Share by States (2012-2017)
Figure Revenue Market Share of Carbidopa by States (2012-2017)
Table United States Carbidopa Price by States (2012-2017)
Table United States Carbidopa Sales by Type (2012-2017)
Table United States Carbidopa Sales Share by Type (2012-2017)
Figure United States Carbidopa Sales Market Share by Type in 2015
Table United States Carbidopa Revenue and Market Share by Type (2012-2017)
Table United States Carbidopa Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Carbidopa by Type (2012-2017)
Table United States Carbidopa Price by Type (2012-2017)
Figure United States Carbidopa Sales Growth Rate by Type (2012-2017)
Table United States Carbidopa Sales by Application (2012-2017)
Table United States Carbidopa Sales Market Share by Application (2012-2017)
Figure United States Carbidopa Sales Market Share by Application in 2015
Table United States Carbidopa Sales Growth Rate by Application (2012-2017)
Figure United States Carbidopa Sales Growth Rate by Application (2012-2017)
Table Novartis Basic Information List
Table Novartis Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Carbidopa Sales Market Share (2012-2017)
Table Merck Sharp & Dohme Basic Information List
Table Merck Sharp & Dohme Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Sharp & Dohme Carbidopa Sales Market Share (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)
Table AbbVie Carbidopa Sales Market Share (2012-2017)
Table Impax Basic Information List
Table Impax Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)
Table Impax Carbidopa Sales Market Share (2012-2017)
Table WOCKHARDT Basic Information List
Table WOCKHARDT Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)
Table WOCKHARDT Carbidopa Sales Market Share (2012-2017)
Table Allergan Basic Information List
Table Allergan Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)
Table Allergan Carbidopa Sales Market Share (2012-2017)
Table Teva Pharmaceuticals Basic Information List
Table Teva Pharmaceuticals Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)
Table Teva Pharmaceuticals Carbidopa Sales Market Share (2012-2017)
Table Mylan N.V. Basic Information List
Table Mylan N.V. Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)
Table Mylan N.V. Carbidopa Sales Market Share (2012-2017)
Table Valeant Basic Information List
Table Valeant Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)
Table Valeant Carbidopa Sales Market Share (2012-2017)
Table Jinghua Pharmaceutical Basic Information List
Table Jinghua Pharmaceutical Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)
Table Jinghua Pharmaceutical Carbidopa Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Carbidopa
Figure Manufacturing Process Analysis of Carbidopa
Figure Carbidopa Industrial Chain Analysis
Table Raw Materials Sources of Carbidopa Major Manufacturers in 2015
Table Major Buyers of Carbidopa
Table Distributors/Traders List
Figure United States Carbidopa Production and Growth Rate Forecast (2017-2022)
Figure United States Carbidopa Revenue and Growth Rate Forecast (2017-2022)
Table United States Carbidopa Production Forecast by Type (2017-2022)
Table United States Carbidopa Consumption Forecast by Application (2017-2022)
Table United States Carbidopa Sales Forecast by States (2017-2022)
Table United States Carbidopa Sales Share Forecast by States (2017-2022)